These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30277170)

  • 1. Hepatitis B Seroepidemiology in Australia, One Decade After Universal Vaccination of Infants and Adolescents.
    Lu X; Quinn HE; Menzies RI; Hueston L; Gilbert L; McIntyre PB
    Infect Disord Drug Targets; 2020; 20(3):341-347. PubMed ID: 30277170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis-B virus infection in India: Findings from a nationally representative serosurvey, 2017-18.
    Murhekar MV; Santhosh Kumar M; Kamaraj P; Khan SA; Allam RR; Barde P; Dwibedi B; Kanungo S; Mohan U; Mohanty SS; Roy S; Sagar V; Savargaonkar D; Tandale BV; Topno RK; Girish Kumar CP; Sabarinathan R; Bitragunta S; Grover GS; Lakshmi PVM; Mishra CM; Sadhukhan P; Sahoo PK; Singh SK; Yadav CP; Kumar R; Dutta S; Toteja GS; Gupta N; Mehendale SM;
    Int J Infect Dis; 2020 Nov; 100():455-460. PubMed ID: 32896662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of hepatitis B in two period birth cohorts of Bolivian children: effect of universal vaccination.
    Masuet-Aumatell C; Ramon-Torrell JM; Casanova-Rituerto A; Banqué-Navarro M; Dávalos-Gamboa Mdel R; Rodríguez SL
    Trans R Soc Trop Med Hyg; 2013 Sep; 107(9):578-83. PubMed ID: 23851262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of hepatitis B virus infection in children 12 years after China's expanded program on immunization in Qamdo, Tibet.
    Hu Y; Ciyang ; Dunzhuyongzong ; Awangluosong ; Yang Z; Aqing
    J Public Health Policy; 2018 Nov; 39(4):446-453. PubMed ID: 30089882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
    Su FH; Chen JD; Cheng SH; Lin CH; Liu YH; Chu FY
    J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
    Ni YH; Chang MH; Jan CF; Hsu HY; Chen HL; Wu JF; Chen DS
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1324-30. PubMed ID: 27155556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
    Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
    Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hepatitis B vaccination on HBV-infection among school children in Yaounde; ten years after the introduction of HBV vaccine into routine Immunization Program in Cameroon.
    Nguwoh PS; Ngounouh CT; Essomba RG; Olinga PZ; Likeng JLN; Nguepidjo G; Douyong SCT; Tchoffo D; Nlend AEN; Assoumou MCO; Fokam J
    Pan Afr Med J; 2024; 47():169. PubMed ID: 39036018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
    Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
    Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
    Miao N; Zheng H; Sun X; Zhang G; Wang F
    Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
    Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the immunization status against hepatitis B and of the prevalence of Ag HBs among Beninese soldiers participating in military missions in Ivory Coast].
    Denis F; Jean S; Alfred V; Jérôme A; Jimy B; Thomas E; Léon TO
    Pan Afr Med J; 2019; 32():19. PubMed ID: 31143324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination.
    Zhang L; Xu A; Yan B; Song L; Li M; Xiao Z; Xu Q; Li L
    Int J Infect Dis; 2010 Jun; 14(6):e483-8. PubMed ID: 19939719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.
    Scognamiglio P; Girardi E; Fusco M; Piselli P; Spena SR; Maione C; Pisanti FA; Serraino D;
    BMC Infect Dis; 2009 Jun; 9():86. PubMed ID: 19500412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy.
    Romanò L; Galli C; Tagliacarne C; Tosti ME; Velati C; Fomiatti L; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zotti CM; Mele A; Zanetti AR;
    Hum Vaccin Immunother; 2017 May; 13(5):981-985. PubMed ID: 28272974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.